Literature DB >> 21099359

BRCA1 modulates the expression of hnRNPA2B1 and KHSRP.

Manuela Santarosa1, Laura Del Col, Alessandra Viel, Nicoletta Bivi, Chiara D'Ambrosio, Andrea Scaloni, Gianluca Tell, Roberta Maestro.   

Abstract

Inactivation of the breast cancer susceptibility gene 1 (BRCA1) plays a significant role in the development of a subset of familial breast and ovarian cancers, but increasing evidence points to a role also in sporadic tumors. BRCA1 is a multifunctional nuclear protein involved in the regulation of many nuclear cellular processes, including DNA repair, cell cycle, transcription and chromatin remodeling. To identify novel proteins participating in the BRCA1 network, two-dimensional gel electrophoresis and MALDI-TOF mass spectrometry were used to compare the nuclear-enriched proteome map of BRCA1-deficient and BRCA1-proficient cell lines. Five differentially expressed polypeptides were identified and two of them, hnRNPA2B1 and KHSRP, turned out to be involved in mRNA and miRNA metabolism. qRT-PCR analyses indicated that the hnRNPA2B1 and KHSRP levels increased in response to BRCA1 loss and restoration of BRCA1 expression in BRCA1 null cells reverted hnRNPA2B1 and KHSRP up-regulation. Interrogation of publicly available transcriptional profiling datasets revealed that both genes were actually over-expressed in BRCA1 mutated tumors. Overall, our results indicate that BRCA1 modulates the expression of two proteins involved in the processing of RNA, highlighting the complex nature of BRCA1-associated tumor suppressor function and disclosing a novel mechanism by which BRCA1 may affect transcription.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21099359      PMCID: PMC3048036          DOI: 10.4161/cc.9.23.14022

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  40 in total

1.  ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins.

Authors:  T Bakheet; M Frevel; B R Williams; W Greer; K S Khabar
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

Review 2.  Messenger-RNA-binding proteins and the messages they carry.

Authors:  Gideon Dreyfuss; V Narry Kim; Naoyuki Kataoka
Journal:  Nat Rev Mol Cell Biol       Date:  2002-03       Impact factor: 94.444

3.  Predominant identification of RNA-binding proteins in Fas-induced apoptosis by proteome analysis.

Authors:  B Thiede; C Dimmler; F Siejak; T Rudel
Journal:  J Biol Chem       Date:  2001-05-14       Impact factor: 5.157

4.  Gene expression profiling predicts clinical outcome of breast cancer.

Authors:  Laura J van 't Veer; Hongyue Dai; Marc J van de Vijver; Yudong D He; Augustinus A M Hart; Mao Mao; Hans L Peterse; Karin van der Kooy; Matthew J Marton; Anke T Witteveen; George J Schreiber; Ron M Kerkhoven; Chris Roberts; Peter S Linsley; René Bernards; Stephen H Friend
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

5.  Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.

Authors:  M Esteller; J M Silva; G Dominguez; F Bonilla; X Matias-Guiu; E Lerma; E Bussaglia; J Prat; I C Harkes; E A Repasky; E Gabrielson; M Schutte; S B Baylin; J G Herman
Journal:  J Natl Cancer Inst       Date:  2000-04-05       Impact factor: 13.506

6.  Gene-expression profiles in hereditary breast cancer.

Authors:  I Hedenfalk; D Duggan; Y Chen; M Radmacher; M Bittner; R Simon; P Meltzer; B Gusterson; M Esteller; O P Kallioniemi; B Wilfond; A Borg; J Trent; M Raffeld; Z Yakhini; A Ben-Dor; E Dougherty; J Kononen; L Bubendorf; W Fehrle; S Pittaluga; S Gruvberger; N Loman; O Johannsson; H Olsson; G Sauter
Journal:  N Engl J Med       Date:  2001-02-22       Impact factor: 91.245

7.  Differential expression of the early lung cancer detection marker, heterogeneous nuclear ribonucleoprotein-A2/B1 (hnRNP-A2/B1) in normal breast and neoplastic breast cancer.

Authors:  J Zhou; D C Allred; I Avis; A Martínez; M D Vos; L Smith; A M Treston; J L Mulshine
Journal:  Breast Cancer Res Treat       Date:  2001-04       Impact factor: 4.872

8.  Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers.

Authors:  Amir A Jazaeri; Cindy J Yee; Christos Sotiriou; Kelly R Brantley; Jeff Boyd; Edison T Liu
Journal:  J Natl Cancer Inst       Date:  2002-07-03       Impact factor: 13.506

9.  Biochemical characterization of apoptotic cleavage of KH-type splicing regulatory protein (KSRP)/far upstream element-binding protein 2 (FBP2).

Authors:  Heeyoung Seok; Jinsun Cho; Minseok Cheon; Il-Seon Park
Journal:  Protein Pept Lett       Date:  2002-12       Impact factor: 1.890

10.  The RNA-binding protein KSRP promotes decay of beta-catenin mRNA and is inactivated by PI3K-AKT signaling.

Authors:  Roberto Gherzi; Michele Trabucchi; Marco Ponassi; Tina Ruggiero; Giorgio Corte; Christoph Moroni; Ching-Yi Chen; Khalid S Khabar; Jens S Andersen; Paola Briata
Journal:  PLoS Biol       Date:  2006-12       Impact factor: 8.029

View more
  13 in total

1.  Different effects of long noncoding RNA NDRG1-OT1 fragments on NDRG1 transcription in breast cancer cells under hypoxia.

Authors:  Ching-Ching Yeh; Jun-Liang Luo; Nam Nhut Phan; Yi-Chun Cheng; Lu-Ping Chow; Mong-Hsun Tsai; Eric Y Chuang; Liang-Chuan Lai
Journal:  RNA Biol       Date:  2018-12-04       Impact factor: 4.652

2.  KH-type splicing regulatory protein (KHSRP) contributes to tumorigenesis by promoting miR-26a maturation in small cell lung cancer.

Authors:  Lihua Tong; Yingshan Luo; Ting Wei; Linlang Guo; Haihong Wang; Weiliang Zhu; Jian Zhang
Journal:  Mol Cell Biochem       Date:  2016-09-19       Impact factor: 3.396

3.  KH-Type Splicing Regulatory Protein Controls Colorectal Cancer Cell Growth and Modulates the Tumor Microenvironment.

Authors:  Francesco Caiazza; Katarzyna Oficjalska; Miriam Tosetto; James J Phelan; Sinéad Noonan; Petra Martin; Kate Killick; Laura Breen; Fiona O'Neill; Blathnaid Nolan; Simon Furney; Robert Power; David Fennelly; Charles S Craik; Jacintha O'Sullivan; Kieran Sheahan; Glen A Doherty; Elizabeth J Ryan
Journal:  Am J Pathol       Date:  2019-08-09       Impact factor: 4.307

4.  Insights into the roles of hnRNP A2/B1 and AXL in non-small cell lung cancer.

Authors:  Xiao-Han Qu; Jin-Lu Liu; Xin-Wen Zhong; X I Li; Qi-Gang Zhang
Journal:  Oncol Lett       Date:  2015-07-03       Impact factor: 2.967

5.  The far-upstream element-binding protein 2 is correlated with proliferation and doxorubicin resistance in human breast cancer cell lines.

Authors:  Ying-Ying Wang; Xiao-Ling Gu; Chao Wang; Hua Wang; Qi-Chao Ni; Chun-Hui Zhang; Xia-Fei Yu; Li-Yi Yang; Zhi-Xian He; Guo-Xin Mao; Shu-Yun Yang
Journal:  Tumour Biol       Date:  2016-01-25

6.  Differential network analysis reveals the genome-wide landscape of estrogen receptor modulation in hormonal cancers.

Authors:  Tzu-Hung Hsiao; Yu-Chiao Chiu; Pei-Yin Hsu; Tzu-Pin Lu; Liang-Chuan Lai; Mong-Hsun Tsai; Tim H-M Huang; Eric Y Chuang; Yidong Chen
Journal:  Sci Rep       Date:  2016-03-14       Impact factor: 4.379

7.  The Autophagy Machinery Contributes to E-cadherin Turnover in Breast Cancer.

Authors:  Valentina Damiano; Paola Spessotto; Giulia Vanin; Tiziana Perin; Roberta Maestro; Manuela Santarosa
Journal:  Front Cell Dev Biol       Date:  2020-06-30

8.  Long non-coding RNA FAM83H-AS1 acts as a potential oncogenic driver in human ovarian cancer.

Authors:  Xiaolei Yuan; Ying Huang; Man Guo; Xiaowei Hu; Peiling Li
Journal:  J Ovarian Res       Date:  2021-01-07       Impact factor: 4.234

9.  Genome-wide RNAi screening identifies genes inhibiting the migration of glioblastoma cells.

Authors:  Jian Yang; Jing Fan; Ying Li; Fuhai Li; Peikai Chen; Yubo Fan; Xiaofeng Xia; Stephen T Wong
Journal:  PLoS One       Date:  2013-04-12       Impact factor: 3.240

Review 10.  Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance.

Authors:  James A McCubrey; Linda S Steelman; William H Chappell; Stephen L Abrams; Richard A Franklin; Giuseppe Montalto; Melchiorre Cervello; Massimo Libra; Saverio Candido; Grazia Malaponte; Maria C Mazzarino; Paolo Fagone; Ferdinando Nicoletti; Jörg Bäsecke; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Michele Milella; Agostino Tafuri; Francesca Chiarini; Camilla Evangelisti; Lucio Cocco; Alberto M Martelli
Journal:  Oncotarget       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.